Dermatoscopes market seen reaching $2.73 billion by 2030

The Business Research Company projects the global dermatoscopes market will grow from $1.53 billion in 2025 to $1.72 billion in 2026, then reach $2.73 billion by 2030. Rising skin cancer screening, AI-assisted diagnosis, teledermatology and portable point-of-care tools are driving demand, with North America holding the largest share in 2025.

Why it matters: - Dermatoscopes are becoming more important as skin cancer diagnoses rise and clinicians push for earlier, more accurate lesion detection. - The market’s growth signals wider adoption of handheld diagnostic tools in dermatology, primary care and remote care settings. - A larger installed base of dermatoscopes could improve access to point-of-care skin exams and support faster referral decisions.

What happened: - The Business Research Company said the global dermatoscopes market will increase from $1.53 billion in 2025 to $1.72 billion in 2026. - The report puts 2026 growth at a 12.4% CAGR. - The market is forecast to reach $2.73 billion by 2030, representing a 12.2% CAGR from 2026 to 2030. - The report is titled "The Business Research Company's Dermatoscopes Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035." - The company said North America held the largest share of the global dermatoscopes market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download a free sample of the report. - View the full market report.

The details: - A dermatoscope is a handheld instrument that uses visible light, including incandescent or LED bulbs, to examine skin lesions and conditions such as melanoma. - The device combines magnification and illumination to improve visualization of the skin’s surface. - Dermatoscopes are also used to inspect the scalp, hair and nails. - The report cites increased awareness of skin cancer screening, wider availability of handheld diagnostic devices, more outpatient dermatology visits, broader adoption of dermoscopy in primary care and advances in optical magnification technology as historical growth drivers. - The forecast period is expected to be supported by connected diagnostic tools, AI-assisted clinical decision support systems, remote dermatology consultations, quick point-of-care diagnostics and integration with mobile platforms. - The report identifies digital and hybrid dermatoscopes, AI-based lesion analysis, portable diagnostic devices, teledermatology-compatible instruments and early melanoma detection as key trends. - Cancer Australia projected about 17,443 new melanoma cases in 2025, including 10,187 among males and 7,256 among females. - Cancer Australia estimated the lifetime risk of developing melanoma by age 85 at 1 in 19 overall, 1 in 16 for males and 1 in 23 for females.

Between the lines: - The forecast reflects a broader shift in dermatology toward connected devices that can support faster screening and easier data sharing. - AI and teledermatology are no longer peripheral features in this category; they are becoming central to product development and buying decisions. - The report’s regional split suggests North America remains the most mature market, while other regions may offer growth through expanding access and screening capacity.

What's next: - The report expects continued demand for portable and mobile-linked dermatoscopes as clinics look for faster diagnostic workflows. - Vendors are likely to keep emphasizing digital imaging, AI support and teledermatology compatibility in new products. - The company also highlighted updated 2026 report features, including market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables. - The Business Research Company listed Saumya Sahay as a contact for expert inquiries.